452 related articles for article (PubMed ID: 33365208)
21. The neuronal ceroid-lipofuscinoses.
Bennett MJ; Rakheja D
Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013
[TBL] [Abstract][Full Text] [Related]
22. Neurophysiological Findings in Neuronal Ceroid Lipofuscinoses.
Trivisano M; Ferretti A; Calabrese C; Pietrafusa N; Piscitello L; Carfi' Pavia G; Vigevano F; Specchio N
Front Neurol; 2022; 13():845877. PubMed ID: 35280270
[TBL] [Abstract][Full Text] [Related]
23. Genetics of the neuronal ceroid lipofuscinoses (Batten disease).
Mole SE; Cotman SL
Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2237-41. PubMed ID: 26026925
[TBL] [Abstract][Full Text] [Related]
24. Cynomolgus macaque model of neuronal ceroid lipofuscinosis type 2 disease.
Munesue Y; Ageyama N; Kimura N; Takahashi I; Nakayama S; Okabayashi S; Katakai Y; Koie H; Yagami KI; Ishii K; Tamaoka A; Yasutomi Y; Shimozawa N
Exp Neurol; 2023 May; 363():114381. PubMed ID: 36918063
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of neuronal ceroid lipofuscinosis: mutation detection strategies.
Getty AL; Rothberg PG; Pearce DA
Expert Opin Med Diagn; 2007 Nov; 1(3):351-62. PubMed ID: 23489355
[TBL] [Abstract][Full Text] [Related]
26. Progress in gene and cell therapies for the neuronal ceroid lipofuscinoses.
Donsante A; Boulis NM
Expert Opin Biol Ther; 2018 Jul; 18(7):755-764. PubMed ID: 29936867
[TBL] [Abstract][Full Text] [Related]
27. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis.
Cooper JD; Russell C; Mitchison HM
Biochim Biophys Acta; 2006 Oct; 1762(10):873-89. PubMed ID: 17023146
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics of the neuronal ceroid lipofuscinoses.
Mole S; Gardiner M
Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748
[TBL] [Abstract][Full Text] [Related]
29. Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders.
Kim K; Kleinman HK; Lee HJ; Pahan K
Orphanet J Rare Dis; 2017 Jun; 12(1):113. PubMed ID: 28623936
[TBL] [Abstract][Full Text] [Related]
30. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038
[TBL] [Abstract][Full Text] [Related]
31. Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models.
Sohar I; Sleat DE; Jadot M; Lobel P
J Neurochem; 1999 Aug; 73(2):700-11. PubMed ID: 10428067
[TBL] [Abstract][Full Text] [Related]
32. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
Kida E; Golabek AA; Wisniewski KE
Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
[TBL] [Abstract][Full Text] [Related]
33. The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy.
Miller JN; Kovács AD; Pearce DA
Hum Mol Genet; 2015 Jan; 24(1):185-96. PubMed ID: 25205113
[TBL] [Abstract][Full Text] [Related]
34. Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.
Katz ML; Rustad E; Robinson GO; Whiting REH; Student JT; Coates JR; Narfstrom K
Neurobiol Dis; 2017 Dec; 108():277-287. PubMed ID: 28860089
[TBL] [Abstract][Full Text] [Related]
35.
Kasapkara ÇS; Ceylan AC; Yılmaz D; Kıreker Köylü O; Yürek B; Civelek Ürey B; Gündüz M
Mol Syndromol; 2023 Feb; 14(1):30-34. PubMed ID: 36777709
[TBL] [Abstract][Full Text] [Related]
36. Biochemistry of neuronal ceroid lipofuscinoses.
Junaid MA; Pullarkat RK
Adv Genet; 2001; 45():93-106. PubMed ID: 11332778
[TBL] [Abstract][Full Text] [Related]
37. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients.
Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN
Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312
[TBL] [Abstract][Full Text] [Related]
38. Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis.
Vuillemenot BR; Kennedy D; Cooper JD; Wong AM; Sri S; Doeleman T; Katz ML; Coates JR; Johnson GC; Reed RP; Adams EL; Butt MT; Musson DG; Henshaw J; Keve S; Cahayag R; Tsuruda LS; O'Neill CA
Mol Genet Metab; 2015 Feb; 114(2):281-93. PubMed ID: 25257657
[TBL] [Abstract][Full Text] [Related]
39. Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis.
Selden NR; Al-Uzri A; Huhn SL; Koch TK; Sikora DM; Nguyen-Driver MD; Guillaume DJ; Koh JL; Gultekin SH; Anderson JC; Vogel H; Sutcliffe TL; Jacobs Y; Steiner RD
J Neurosurg Pediatr; 2013 Jun; 11(6):643-52. PubMed ID: 23581634
[TBL] [Abstract][Full Text] [Related]
40. Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview.
Simonati A; Williams RE
Front Neurol; 2022; 13():811686. PubMed ID: 35359645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
